All In Biotech

Free tool

FAERS Monitor: Reclast

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022080 or its brand name (Reclast, Zoledronic Acid). Reports on generic versions are filed under their own applications.

Reports

40,714

Serious

35,240

87% of reports

Hospitalization

11,750

Death reported

5,181

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • arthralgia3,285
  • pain3,218
  • fatigue2,877
  • nausea2,875
  • pyrexia2,875
  • osteonecrosis of jaw2,775
  • death2,522
  • headache2,431
  • diarrhoea2,335
  • vomiting2,090
  • asthenia2,015
  • myalgia1,908
  • off label use1,775
  • pain in extremity1,708
  • dyspnoea1,669

Reports by year received

View as table
YearReports
200440
200592
2006108
2007281
2008853
20091,339
20101,535
20112,241
20122,416
2013996
2014809
20151,331
20161,465
20171,673
20182,318
20192,676
20202,708
20212,705
20222,796
20233,043
20243,317
20253,556
20262,415

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,013,445 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
osteonecrosis of jawSignal2,77565.162.7155,684
myalgiaSignal1,9085.95.67,647
pyrexiaSignal2,8754.34.27,393
arthralgiaSignal3,2854.14.07,809
pain in extremitySignal1,7083.02.92,304
astheniaSignal2,0152.82.72,320
painSignal3,2182.72.63,571
vomitingSignal2,0902.32.21,566
headacheSignal2,4312.01.91,260
fatigue2,8771.91.81,295
nausea2,8751.91.81,225
diarrhoea2,3351.91.8974
dyspnoea1,6691.51.5308
death2,5221.51.5457
off label use1,7751.01.04

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.